Skip to Main Content

Paper Details

UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.
J Thorac Oncol
19
2021
MPM, MPM cells, MPM lines, Malignant Pleural Mesothelioma, NMC, NMCs, RNA, UHRF1, Ubiquitin-like with plant homeodomain and ring finger domains 1, cancers, human, malignant pleural mesothelioma, mesothelioma, mithramycin, normal mesothelial cells, p53, patient, patients
Author NameAffiliation
Emily S ReardonCenter for Cancer Research National Cancer Institute, National Institutes of Health
Emily S ReardonCenter for Cancer Research National Cancer Institute, National Institutes of Health
Vivek ShuklaCenter for Cancer Research National Cancer Institute, National Institutes of Health
Vivek ShuklaCenter for Cancer Research National Cancer Institute, National Institutes of Health
Sichuan XiCenter for Cancer Research National Cancer Institute, National Institutes of Health
Sichuan XiCenter for Cancer Research National Cancer Institute, National Institutes of Health
Sudheer Kumar GaraCenter for Cancer Research National Cancer Institute, National Institutes of Health
Sudheer Kumar GaraCenter for Cancer Research National Cancer Institute, National Institutes of Health
Mary ZhangCenter for Cancer Research National Cancer Institute, National Institutes of Health
Mary ZhangCenter for Cancer Research National Cancer Institute, National Institutes of Health
Julie A HongCenter for Cancer Research National Cancer Institute, National Institutes of Health
Julie A HongCenter for Cancer Research National Cancer Institute, National Institutes of Health
Eden C PayabyabCenter for Cancer Research National Cancer Institute, National Institutes of Health
Eden C PayabyabCenter for Cancer Research National Cancer Institute, National Institutes of Health
Markku MiettinenLaboratory of Pathology National Cancer Institute, National Institutes of Health
Markku MiettinenLaboratory of Pathology National Cancer Institute, National Institutes of Health
Mark RaffeldLaboratory of Pathology National Cancer Institute, National Institutes of Health
Mark RaffeldLaboratory of Pathology National Cancer Institute, National Institutes of Health
Xinmin LiUniversity of California, Los Angeles School of Medicine
Cuong Hoang-VuCenter for Cancer Research National Cancer Institute, National Institutes of Health
Raphael BuenoBrigham and Women's Hospital
David S SchrumpCenter for Cancer Research National Cancer Institute, National Institutes of Health
David S SchrumpCenter for Cancer Research National Cancer Institute, National Institutes of Health
  • 1 - 23

Datasets